In Law360, life sciences regulatory & compliance partner Joshua Oyster, counsel Beth Weinman and associate Austin Laroche (all of Washington, D.C.) analyzed the U.S. Food and Drug Administration proposed rule to harmonize its regulations governing good manufacturing practices for medical devices with an international consensus standard, ISO 13485.
The authors note that despite general industry support for the proposed rule, the overwhelming theme from industry stakeholders so far is that one year is not enough time to transition to the international standard.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.